HOWL Stock Catalyst: Werewolf Therapeutics Enters Into Asset Purchase Agreement with EMD Serono

Aug 20, 2026 · 4:06pm ET

The agreement was announced via an 8-K filing.

Max move

+173.7%

High of day $1.19

Sparker timei

4:06pm ET

HOWL · Aug 20, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Werewolf Therapeutics, Inc. (HOWL) entered into an asset purchase agreement with EMD Serono Research & Development Institute, LLC on August 14, 2026. The agreement was disclosed through an 8-K filing.

The filing did not include specific financial details or share considerations related to the transaction.

As of the latest available data, Werewolf Therapeutics has a free float of 42,462,231 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time HOWL sparks.

Download Sniper App →

Catch the next HOWL-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →